GNPX: Genprex, Inc. Stock

by  •  • Comments Off on GNPX: Genprex, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.17
Enterprise Value ($M) 4.57
Book Value ($M) 1.62
Book Value / Share 0.07
Price / Book 3.81
NCAV ($M) -0.43
NCAV / Share -0.02
Price / NCAV -14.46

Profitability (mra)
Return on Invested Capital (ROIC) -13.20
Return on Assets (ROA) -1.70
Return on Equity (ROE) -2.44

Liquidity (mrq)
Quick Ratio 0.83
Current Ratio 0.83

Balance Sheet (mrq) ($M)
Current Assets 2.08
Assets 4.12
Liabilities 2.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -21.17
Net Income -21.39
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -17.15
Cash from Investing 0.00
Cash from Financing 12.01

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-15 13G Forsakringsaktiebolaget Avanza Pension 0.02 -95.43
10-24 13G/A Otsuka Masaya 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 324,607 1,016,362 31.94
2025-04-16 300,624 1,358,903 22.12
2025-04-15 94,906 584,894 16.23

(click for more detail)

Similar Companies
GLTO – Galecto, Inc. GLYC – GlycoMimetics, Inc.
GNLX – Genelux Corporation GOVX – GeoVax Labs, Inc.
GRCE – Grace Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io